Vaccines, Journal Year: 2025, Volume and Issue: 13(5), P. 476 - 476
Published: April 28, 2025
Lung cancer is the most lethal malignancy worldwide, having highest incidence rate. This a heterogeneous disease classified according to its histological and molecular characteristics. Depending on these, different therapeutic approaches have already been approved for lung treatment targeting genetic alterations or even immune system. Nonetheless, other therapies are being studied continuously improve care survival of patients. Among them, immunotherapies one main targets investigation try combat ability some malignant cells evade anti-tumor responses mediated by Cancer vaccine development has emerged as promising approach strengthen patient’s system disease, especially mRNA vaccines. Currently, there several ongoing studies investigating efficacy vaccines in alone combined with drugs. review aims highlight importance immunotherapy treatment, presenting recent advances particularly mRNA-based well challenges future perspectives.
Language: Английский